ABSTRACT #6: Patient-reported outcomes from a phase III multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy: Cancer Oesophagus Gefitinib - 100004

Spotlight
Video

ABSTRACT #6: Patient-reported outcomes from a phase III multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy: Cancer Oesophagus Gefitinib

imedex has 1284 videos Subscribe Here

Loading........
Description: Dr. Johanna Bendell discusses ABSTRACT #6: Patient-reported outcomes from a phase III multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy: Cancer Oesophagus Gefitini.
Shared By : imedex
Posted on : 02/05/13
Added : 6 years ago
Category : Other